+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Tumor Ablation Therapy Devices Global Market Report 2020-30: COVID-19 Growth and Change

  • ID: 5185309
  • Report
  • November 2020
  • Region: Global
  • 200 pages
  • The Business Research Company
UP TO OFF
until Dec 31st 2020
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Angiodynamics
  • BTG International Ltd
  • EDAP TMS S.A.
  • Galil Medical Inc
  • INTIO Inc.
  • Misonix Inc
  • MORE
Tumor Ablation Therapy Devices Global Market Report 2020-30: COVID 19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global tumor ablation therapy devices market.

This report focuses on tumor ablation therapy devices market which is experiencing strong growth. The report gives a guide to the tumor ablation therapy devices market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the tumor ablation therapy devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Tumor Ablation Therapy Devices market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider tumor ablation therapy devices market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The tumor ablation therapy devices market section of the report gives context. It compares the tumor ablation therapy devices market with other segments of the tumor ablation therapy devices market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, tumor ablation therapy devices indicators comparison.
Scope

Markets Covered:
1) By Technology: Radiofrequency Ablation; Microwave Ablation; Cryoablation; Irreversible Electroporation Ablation; Others
2) By Treatment: Surgical; Laparoscopic; Percutaneous
3) By End User: Hospitals; Oncology Clinics; Others
4) By Application: Kidney Cancer; Liver Cancer; Breast Cancer; Lung Cancer; Prostate Cancer; Others

Companies Mentioned: Galil Medical Inc; Misonix Inc; HealthTronics; Angiodynamics; Boston Scientific Corporation

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Angiodynamics
  • BTG International Ltd
  • EDAP TMS S.A.
  • Galil Medical Inc
  • INTIO Inc.
  • Misonix Inc
  • MORE
1. Executive Summary

2. Tumor Ablation Therapy Devices Market Characteristics

3. Tumor Ablation Therapy Devices Market Size And Growth
3.1. Global Tumor Ablation Therapy Devices Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Tumor Ablation Therapy Devices Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Tumor Ablation Therapy Devices Market Segmentation
4.1. Global Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • Irreversible Electroporation Ablation
  • Others
4.2. Global Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Surgical
  • Laparoscopic
  • Percutaneous
4.3. Global Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospitals
  • Oncology Clinics
  • Others
4.4. Global Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Kidney Cancer
  • Liver Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Others
5. Tumor Ablation Therapy Devices Market Regional And Country Analysis
5.1. Global Tumor Ablation Therapy Devices Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Tumor Ablation Therapy Devices Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Tumor Ablation Therapy Devices Market
6.1. Asia-Pacific Tumor Ablation Therapy Devices Market Overview
6.2. Asia-Pacific Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Tumor Ablation Therapy Devices Market
7.1. China Tumor Ablation Therapy Devices Market Overview
7.2. China Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.3. China Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Tumor Ablation Therapy Devices Market
8.1. India Tumor Ablation Therapy Devices Market Overview
8.2. India Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.3. India Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Tumor Ablation Therapy Devices Market
9.1. Japan Tumor Ablation Therapy Devices Market Overview
9.2. Japan Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.3. Japan Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Tumor Ablation Therapy Devices Market
10.1. Australia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.2. Australia Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Tumor Ablation Therapy Devices Market
11.1. Indonesia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.2. Indonesia Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Tumor Ablation Therapy Devices Market
12.1. South Korea Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.2. South Korea Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Tumor Ablation Therapy Devices Market
13.1. Western Europe Tumor Ablation Therapy Devices Market Overview
13.2. Western Europe Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.3. Western Europe Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Tumor Ablation Therapy Devices Market
14.1. UK Tumor Ablation Therapy Devices Market Overview
14.2. UK Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.3. UK Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Tumor Ablation Therapy Devices Market
15.1. Germany Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.2. Germany Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Tumor Ablation Therapy Devices Market
16.4. France Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.5. France Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Tumor Ablation Therapy Devices Market
17.1. Eastern Europe Tumor Ablation Therapy Devices Market Overview
17.2. Eastern Europe Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Tumor Ablation Therapy Devices Market
18.1. Russia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.2. Russia Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Tumor Ablation Therapy Devices Market
19.1. North America Tumor Ablation Therapy Devices Market Overview
19.2. North America Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.3. North America Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Tumor Ablation Therapy Devices Market
20.1. USA Tumor Ablation Therapy Devices Market Overview
20.2. USA Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.3. USA Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Tumor Ablation Therapy Devices Market
21.1. South America Tumor Ablation Therapy Devices Market Overview
21.2. South America Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.3. South America Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Tumor Ablation Therapy Devices Market
22.1. Brazil Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.2. Brazil Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Tumor Ablation Therapy Devices Market
23.1. Middle East Tumor Ablation Therapy Devices Market Overview
23.2. Middle East Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.3. Middle East Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Tumor Ablation Therapy Devices Market
24.1. Africa Tumor Ablation Therapy Devices Market Overview
24.2. Africa Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.3. Africa Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Tumor Ablation Therapy Devices Market Competitive Landscape And Company Profiles
25.1. Tumor Ablation Therapy Devices Market Competitive Landscape
25.2. Tumor Ablation Therapy Devices Market Company Profiles
25.2.1. Galil Medical Inc
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Misonix Inc
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. HealthTronics
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Angiodynamics
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Boston Scientific Corporation
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Tumor Ablation Therapy Devices Market

27. Tumor Ablation Therapy Devices Market Trends And Strategies

28. Tumor Ablation Therapy Devices Market Future Outlook and Potential Analysis

29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. About the Publisher
29.5. Copyright And Disclaimer
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Angiodynamics
  • BTG International Ltd
  • EDAP TMS S.A.
  • Galil Medical Inc
  • INTIO Inc.
  • Misonix Inc
  • MORE
Major players in the tumor ablation therapy devices market are Galil Medical Inc, Misonix Inc, HealthTronics, Angiodynamics, Boston Scientific Corporation, Medtronic Plc., EDAP TMS S.A., Neuwave Medical Inc, BVM Medical Limited and Erbe Elektromedizin GmbH.

The global tumor ablation therapy devices market is expected to decline from $515.48 million in 2019 to $501.51 million in 2020 at a compound annual growth rate (CAGR) of -2.71%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $728.35 million in 2023 at a CAGR of 13.25%.

The tumor ablation therapy devices market consists of sales of tumor ablation devices and related services that are used in hospitals and oncology clinics. Tumor ablation is the technique used to extract the tumors using a needle, to insert it in the tumor organ using imaging techniques.

North America was the largest region in the tumor ablation therapy devices market in 2019.

The tumor ablation therapy devices market covered in this report is segmented by technology into radiofrequency ablation; microwave ablation; cryoablation; irreversible electroporation ablation; others. It is also segmented by treatment into surgical; laparoscopic; percutaneous, by end user into hospitals; oncology clinics; others and by application into kidney cancer; liver cancer; breast cancer; lung cancer; prostate cancer; others.

In June 2019, Varian Medical Systems acquired Endocare for an undisclosed amount. This acquisition will help Varian Medical Systems strengthen its portfolio by adding cryoablation and microwave ablation therapies and embolic beads to its cancer care solutions portfolio. Endocare is a leading provider of hardware and software solutions supporting cryoablation and microwave ablation.

Product recalls of tumor ablation devices due to technical issues is expected to hinder the growth of the tumor ablation therapy devices market. The companies are retrieving their products from the market due to safety concerns. For instance, in November 2018, Covidien Emprint Long Percutaneous Antenna with Thermosphere Technology, a tumor ablation device from Medtronic had recalled its devices due to disengagement of ceramic trocar tip of the Emprint ablation from the needle shaft post-ablation. Similarly, in June 2018, Accurian RF Ablation by Medtronic Sofamor Danek USA Inc was recalled due to the difficulty in insertion. The product recalls cause a financial burden on the companies hindering the tumor ablation therapy devices market.

Major companies operating in the tumor ablation therapy devices are focusing on technology advancements for shorter procedures, increased safety, lower exposure to radiation, faster learning curves and improved outcomes. In 2018, J&J medicals have released a microwave ablation system called NEUWAVE, which is the first minimally invasive device to put electrodes into cancer cells and thereby increase the temperature around them for burning the cancer cells. In June 2020, Boston Scientific has launched a technology called DirectSense technology, a tool used for monitoring the effect of radiofrequency (RF) now for cardiac procedures, which may be further employed for tumors.

The increasing prevalence of cancer is a key factor driving the growth of the tumor ablation therapy devices market. Cancer is considered to be the second major cause of death, with around 1 in 6 deaths due to cancer worldwide. Tumor ablation is a minimally invasive procedure widely used in the treatment of lung, liver, kidney and bone tumors. According to the World Health Organization (WHO), 9.6 million deaths occurred in 2018 due to cancer and about 70% of deaths from cancer occur in low- and middle-income countries. The procedure is an effective method for patients who have failed chemotherapy or radiotherapy, thereby supporting the growth of the tumor ablation therapy devices market.
Note: Product cover images may vary from those shown
4 of 5
  • Galil Medical Inc
  • Misonix Inc
  • HealthTronics
  • Angiodynamics
  • Boston Scientific Corporation
  • Medtronic Plc.
  • EDAP TMS S.A.
  • Neuwave Medical Inc
  • BVM Medical Limited
  • Erbe Elektromedizin GmbH
  • BTG International Ltd
  • AtriCure, Inc.
  • Theraclion
  • INTIO Inc.
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll